Compare RVMD & RYAAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RVMD | RYAAY |
|---|---|---|
| Founded | 2014 | 1985 |
| Country | United States | Ireland |
| Employees | 883 | 25952 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Air Freight/Delivery Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.1B | 30.7B |
| IPO Year | N/A | N/A |
| Metric | RVMD | RYAAY |
|---|---|---|
| Price | $154.30 | $60.83 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 19 | 2 |
| Target Price | ★ $140.84 | $78.00 |
| AVG Volume (30 Days) | ★ 2.0M | 1.6M |
| Earning Date | 05-06-2026 | 05-18-2026 |
| Dividend Yield | N/A | ★ 1.54% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $11.99 |
| Revenue Next Year | $533.02 | $6.32 |
| P/E Ratio | ★ N/A | $12.60 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $34.00 | $53.14 |
| 52 Week High | $156.25 | $74.24 |
| Indicator | RVMD | RYAAY |
|---|---|---|
| Relative Strength Index (RSI) | 62.04 | 58.70 |
| Support Level | $93.39 | $60.51 |
| Resistance Level | N/A | $61.47 |
| Average True Range (ATR) | 5.02 | 1.50 |
| MACD | -0.50 | 0.80 |
| Stochastic Oscillator | 81.16 | 85.54 |
Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.
Ryanair is Europe's largest low-cost airline, known for its extensive network and highly efficient business model. Operating over 3,600 flights daily across 240-plus destinations in 40 countries, Ryanair has built its success on offering affordable air travel while maintaining tight control over costs. The airline primarily uses Boeing 737 aircraft, including the newer 737 8-200 "Gamechanger" variant, which simplifies operations and reduces expenses. Ryanair focuses on high passenger volume, ancillary revenue, and operational efficiency, ensuring its position as a leading airline in Europe.